A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis

NCT05775094 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis
Multiple Myeloma

Interventions

DRUG: Romosozumab

Sponsor

Memorial Sloan Kettering Cancer Center